
     RDKit          2D

 22 22  0  0  0  0  0  0  0  0999 V2000
   -0.0296   -2.1434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3829   -1.4289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0296   -0.7145    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3829    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2079    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6204    0.7145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2079    1.4289    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6204    2.1434    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    2.0329    2.8579    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9059    2.5559    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3349    1.7309    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6204   -0.7145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4454   -0.7145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8579    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6829    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6829   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6829    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5079    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9204   -0.7145    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9204    0.7145    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2079   -1.4289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6204   -2.1434    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2 21  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5 12  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
  8 11  2  0
 12 13  1  0
 12 21  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 15 18  1  0
 18 19  1  0
 18 20  2  0
 21 22  1  0
M  END
>  <DRUGBANK_ID>  (1) 
DB04241

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
EXPT02361

>  <COMMON_NAME>  (1) 
N-Pyridoxyl-2-Methylalanine-5-Phosphate

$$$$
